Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
ImageneBio, Inc. (IMA) had Consolidated Net Income/Loss of $-10.18M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-10.18M |
|
-- |
|
-- |
|
$11.78M |
|
$-11.78M |
|
$1.62M |
|
$-10.16M |
|
$-10.16M |
|
$-10.18M |
|
$-10.18M |
|
|
Consolidated Net Income/Loss |
$-10.18M |
$-10.18M |
|
$-11.78M |
|
$-11.61M |
|
16.16M |
|
16.16M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$141.11M |
|
-- |
|
$10.93M |
|
$152.04M |
|
$6.57M |
|
-- |
|
$3.40M |
|
$9.97M |
|
$142.07M |
|
$142.07M |
|
$142.07M |
|
11.81M |
|
| Cash Flow Statement Financials | |
$-23.87M |
|
$-0.79M |
|
$24.80M |
|
$94.53M |
|
$94.68M |
|
$0.14M |
|
$1.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.16% |
|
-7.16% |
|
-6.69% |
|
-7.16% |
|
$12.03 |
|
$-1.48 |
|
$-1.48 |
|